Growing community of inventors

Nara, Japan

Sae Akao

Average Co-Inventor Count = 5.46

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Sae AkaoKomei Okabe (1 patent)Sae AkaoShinji Yoneda (1 patent)Sae AkaoHirotada Akiyama (1 patent)Sae AkaoYasufumi Murakami (1 patent)Sae AkaoAtsushi Yoshida (1 patent)Sae AkaoTatsuji Kurose (1 patent)Sae AkaoHiroyuki Satofuka (1 patent)Sae AkaoShigeki Mukoubata (1 patent)Sae AkaoTomomi Kohara (1 patent)Sae AkaoSae Akao (2 patents)Komei OkabeKomei Okabe (5 patents)Shinji YonedaShinji Yoneda (5 patents)Hirotada AkiyamaHirotada Akiyama (4 patents)Yasufumi MurakamiYasufumi Murakami (4 patents)Atsushi YoshidaAtsushi Yoshida (4 patents)Tatsuji KuroseTatsuji Kurose (3 patents)Hiroyuki SatofukaHiroyuki Satofuka (3 patents)Shigeki MukoubataShigeki Mukoubata (3 patents)Tomomi KoharaTomomi Kohara (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Santen Pharmaceutical Co., Ltd. (2 from 281 patents)

2. Order-made Medical Research Inc. (1 from 5 patents)


2 patents:

1. 11008387 - Antibody inhibiting binding of VEGF to NRP1

2. 9579309 - Prophylactic or therapeutic agent for posterior ocular disease containing tetrahydropyranylaminocyclopentylcarbonyltetrahydropyridopyridine derivative as effective ingredient

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/29/2025
Loading…